“Make Me a Sanctuary”

2021 ◽  
pp. 1-10
Author(s):  
Ariel Feldman ◽  
Faina Feldman
Keyword(s):  
Mount Sinai

Abstract This contribution offers a new reading and reconstruction of an addition found in the text of Exod 24:18–25:1 as preserved in 4Q364 (4QRPb) 15. Alluding to Exod 25:8 (and possibly 9), it appears to elucidate the purpose of Moses’s forty days’ long stay atop Mount Sinai and serves as a nexus between Exod 24:18 and the following discussion of the Tabernacle.

The Movement of Ezekiel’s “Living Beings” in 4Q405 Shirot ‘Olat Hashabbat. Part II: The Twelfth Song

2018 ◽  
Vol 27 (1) ◽  
Author(s):  
Annette Evans
Keyword(s):  
Explicit Description ◽  
Plural Form ◽  
The Law ◽  
Mount Sinai

In this article descriptions of angelic movement in the Twelfth Song are compared to descriptions of such activity arising from the throne of God in Ezekiel’s vision in Ezekiel 1 and 10, and to that in the Seventh Song as contained in scroll 4Q403. The penultimate Twelfth Song of the Songs of the Sabbath Sacrifice culminates in a more explicit description of angelic messenger activity and in other nuances. The Twelfth Song was intended to be read on the Sabbath immediately following Shavu’ot, when the traditional synagogue reading is Ezekiel 1 and Exodus 19–20. The possible significance for the author of Songs of the Sabbath Sacrifice of the connection between the giving of the Law at Mount Sinai and Ezekiel’s vision where merkebah thrones and seats appear in the plural form is considered in the conclusion

Mount Sinai

2010 ◽  
Author(s):  
A. Mary R. Dobson
Keyword(s):  
Mount Sinai

scholarly journals Multiplex Assays of Luminex for Identification of COVID-19 Antibodies in Patient Serum: Performance Evaluation and Comparison to ELISA

2020 ◽  
Vol 154 (Supplement_1) ◽  
pp. S92-S92
Author(s):  
M S Shapiro ◽  
X Wang ◽  
D R Mendu ◽  
A Firpo
Keyword(s):  
Dynamic Range ◽  
High Titer ◽  
Mount Sinai Hospital ◽  
Antibody Testing ◽  
Luminex Assay ◽  
Multiplex Assays ◽  
Negative Results ◽  
Broad Dynamic Range ◽  
Circulating Antibodies ◽  
Mount Sinai

Abstract Introduction/Objective Mount Sinai Hospital has received emergency use authorization (EUA) from the FDA for Coronavirus Disease 2019 (COVID-19) antibody testing using ELISA. This serological assay detects and titrates the presence of circulating antibodies to COVID-19. Other platforms have aimed to achieve the credentials of the ELISA instrument, including the multiplex assays of Luminex. The platform is known to have a greater throughput (384 wells vs. 96 wells per microplate) and faster processing speed (8 hours vs. 17 hours). Methods Luminex utilizes beads that couple to the same COVID-19 antigens (mRBD and mSpike) which were utilized for the ELISA assay. The beads are read determining the mean fluorescence intensity (MFI). In order to compare the two methods, our study included 61 patients with COVID-19 at Mount Sinai Hospital, to screen and titrate their sera using Luminex, and to correspond the MFI values with the ELISA titers. Results The Luminex assay has achieved the same level of confidence as ELISA. The 61 patients, representing 30 negatives and 31 positives, are consistently identified as such on both platforms. Our data highlights 32% of patients with a low titer (<1:160), 42% of patients with a high titer (1:160 ~ 1:320), and 26% of patients with a very high titer level (>1:320). These titers correlated well with the MFI values. Based on a cutoff of 80,000 MFI, the sensitivity and specificity of the assay is 98% and 85%, respectively, with no overlapping of MFI between positive and negative results. Conclusion Overall, the study has demonstrated that the Luminex is a strong alternative for the ELISA platform. The Luminex highlights the broad dynamic range with no overlapping between positives and negatives. Migration from ELISA to Luminex, a platform with faster and greater throughput, is therefore, highly desirable.

The Mount Sinai (New York) Visiting Doctors Program: Meeting the Needs of the Urban Homebound Population

2011 ◽  
Vol 12 (4) ◽  
pp. 139-143 ◽  
Author(s):  
Katherine Ornstein ◽  
Cameron R. Hernandez ◽  
Linda V. DeCherrie ◽  
Theresa A. Soriano
Keyword(s):  
New York ◽  
Social Work ◽  
Clinical Care ◽  
Older Individuals ◽  
Social Service Agencies ◽  
Complex Needs ◽  
Home Based ◽  
Major Teaching ◽  
Mount Sinai ◽  
Physician Availability

The Mount Sinai Visiting Doctors program, a joint program of Mount Sinai Medical Center’s Departments of Medicine and Geriatrics, is a large multidisciplinary teaching, research, and clinical care initiative serving homebound adults in Manhattan since 1995. Caring for more than 1,000 patients annually, the physicians of Visiting Doctors make more than 6,000 urgent and routine visits each year, making it the largest program of its kind in the country. Services include 24–hour physician availability, palliative care, social work case management, collaboration with nursing agencies, and in-home specialty consultation. The program serves many individuals who have previously received inadequate and inconsistent medical care. Patients are referred by social service agencies, local physicians, and hospitals and are primarily frail older individuals with complex needs. Funded by Mount Sinai and private support, the program serves as a major teaching site for medical, nursing, and social work trainees interested in home-based primary care.

Neurosurgery at the Mount Sinai Hospital

1994 ◽  
Vol 80 (5) ◽  
pp. 935-938 ◽  
Author(s):  
Jeffrey S. Oppenheim
Keyword(s):  
Mount Sinai Hospital ◽  
Content Type ◽  
History Of Neurosurgery ◽  
History Of ◽  
Mount Sinai ◽  
Fine Print

✓ The Mount Sinai Hospital was founded in 1852 under the name “The Jews' Hospital.” Neurosurgery at Mount Sinai Hospital can be traced to the work of Dr. Charles Elsberg. In 1932, the Department of Neurosurgery was created under the direction of Dr. Ira Cohen. The history of neurosurgery at the Mount Sinai Hospital is recounted.

Sign in / Sign up

Export Citation Format

Share Document